Analystreport

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $15.00 to $13.00. They now have an "outperform" rating on the stock.

Aurinia Pharmaceuticals Inc - Common Shares  (AUPH) 
Last aurinia pharmaceuticals inc - common shares earnings: 3/5 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.auriniapharma.com